Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00419263Phase 2Completed
A Phase 2 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00419263.